Gemfibrozil and Vaginal bleeding - a phase IV clinical study of FDA data

Summary:

Vaginal bleeding is reported as a side effect among people who take Gemfibrozil (gemfibrozil), especially for people who are 60+ old, have been taking the drug for 1 - 6 months also take Digoxin, and have Diabetes.

The phase IV clinical study analyzes which people have Vaginal bleeding when taking Gemfibrozil. It is created by eHealthMe based on reports of 17,763 people who have side effects when taking Gemfibrozil from the FDA, and is updated regularly.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

What is Vaginal bleeding?

Vaginal bleeding is found to be associated with 1,129 drugs and 1,538 conditions by eHealthMe. Check the latest studies of Vaginal bleeding.

On Aug, 04, 2026

17,763 people reported to have side effects when taking Gemfibrozil.
Among them, 18 people (0.1%) have Vaginal bleeding.

Could Gemfibrozil cause Vaginal bleeding?

Among these 18 people:

How long have people been on Gemfibrozil when they have Vaginal bleeding? *

What is the age of people who have Vaginal bleeding when taking Gemfibrozil? *

What are other drugs people take besides Gemfibrozil? *

What are other side effects people have besides Vaginal bleeding? *

Weakness: 3 people, 16.67%
Urinary Tract Infection: 3 people, 16.67%
Hypokalemia (low potassium): 3 people, 16.67%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 16.67%
Fatigue (feeling of tiredness): 3 people, 16.67%
Diarrhea: 2 people, 11.11%
Fall: 2 people, 11.11%
Common Peroneal Nerve Dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes): 2 people, 11.11%
Nausea (feeling of having an urge to vomit): 2 people, 11.11%
Foot Fracture: 2 people, 11.11%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 16.67%
Diabetes: 3 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.11%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 11.11%
Conjunctivitis (pink eye): 2 people, 11.11%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
Type 2 Diabetes: 1 person, 5.56%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.56%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.56%
Neuropathy Peripheral (surface nerve damage): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Gemfibrozil and have Vaginal bleeding?

- Check whether Vaginal bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemfibrozil:

Gemfibrozil (18,213 reports)

Vaginal bleeding treatments and more:

Vaginal bleeding (49,485 reports)

Browse all side effects of Gemfibrozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vaginal bleeding:

Vaginal bleeding (1,129 drugs)

Browse all the conditions that are associated with Vaginal bleeding:

Vaginal bleeding (1,538 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Gemfibrozil) and Gemfibrozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.